Compositions and methods for inhibition of the JAK pathway

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S317000

Reexamination Certificate

active

07947698

ABSTRACT:
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, are therapeutically useful.

REFERENCES:
patent: 7060827 (2006-06-01), Singh et al.
patent: 7122542 (2006-10-01), Singh et al.
patent: 7329671 (2008-02-01), Singh et al.
patent: 7329672 (2008-02-01), Singh et al.
patent: 7332484 (2008-02-01), Singh et al.
patent: 7452879 (2008-11-01), Singh et al.
patent: 2004/0029902 (2004-02-01), Singh et al.
patent: 2005/0209230 (2005-09-01), Singh et al.
patent: 2005/0234049 (2005-10-01), Singh et al.
patent: 2006/0035891 (2006-02-01), Li et al.
patent: 2006/0058525 (2006-03-01), Singh et al.
patent: 2006/0135543 (2006-06-01), Singh et al.
patent: 2006/0167254 (2006-07-01), Cooper et al.
patent: 2006/0211657 (2006-09-01), Singh et al.
patent: 2006/0234983 (2006-10-01), Singh et al.
patent: 2006/0270694 (2006-11-01), Wong
patent: 2006/0293311 (2006-12-01), Li et al.
patent: 2007/0004626 (2007-01-01), Masuda et al.
patent: 2007/0060603 (2007-03-01), Singh et al.
patent: 2007/0117775 (2007-05-01), Payan
patent: 2007/0129360 (2007-06-01), Bhamidipati et al.
patent: 2007/0129362 (2007-06-01), Bhamidipati et al.
patent: 2007/0191405 (2007-08-01), Noronha et al.
patent: 2007/0197782 (2007-08-01), Clough et al.
patent: 2007/0203161 (2007-08-01), Argade et al.
patent: 2007/0203162 (2007-08-01), Li et al.
patent: 2007/0225321 (2007-09-01), Singh et al.
patent: 2007/0225495 (2007-09-01), Singh et al.
patent: 2007/0293520 (2007-12-01), Singh et al.
patent: 2007/0293521 (2007-12-01), Singh et al.
patent: 2007/0293522 (2007-12-01), Singh et al.
patent: 2007/0293523 (2007-12-01), Singh et al.
patent: 2007/0293524 (2007-12-01), Singh et al.
patent: 2007/0299095 (2007-12-01), Singh et al.
patent: 2008/0039622 (2008-02-01), Singh et al.
patent: 2008/0194603 (2008-08-01), Li et al.
patent: 2008/0221089 (2008-09-01), Argade et al.
patent: 2008/0260754 (2008-10-01), Li et al.
patent: 2008/0306099 (2008-12-01), Li et al.
patent: 2006/021454 (2006-03-01), None
patent: WO 2006/021454 (2006-03-01), None
patent: WO 2007/053452 (2007-05-01), None
Vippagunta et al., “Crystalline Solids”, Adv. Drug Del. Rev., 48 (2001) 3-26.
U.S. Appl. No. 11/539,142, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/539,074, filed Oct. 5, 2006, Singh et al.
U.S. Appl. No. 11/943,506, filed Nov. 20, 2007, Bhamidipati et al.
U.S. Appl. No. 12/028,581, filed Feb. 8, 2008, Argade et al.
U.S. Appl. No. 12/030,031, filed Feb. 12, 2008, Li et al.
U.S. Appl. No. 12/175,441, filed Jul. 17, 2008, Singh et al.
U.S. Appl. No. 12/193,627, filed Aug. 18, 2008, Li et al.
U.S. Appl. No. 12/199,705, filed Aug. 27, 2008, Singh et al.
U.S. Appl. No. 12/268,235, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/268,218, filed Nov. 10, 2008, Singh et al.
U.S. Appl. No. 12/273,357, filed Nov. 18, 2008, Singh et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for inhibition of the JAK pathway does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for inhibition of the JAK pathway, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for inhibition of the JAK pathway will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2670796

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.